McNeil Specialty Pharmaceuticals

McNeil Specialty Pharmaceuticals is a division of Johnson & Johnson that historically focused on the development and commercialization of both prescription and over-the-counter healthcare products. The company is notably recognized for bringing the ADHD medication Concerta to market and for its stewardship of iconic brands like Tylenol and Motrin. Over the years, its operations have been closely integrated with McNeil Consumer Healthcare and McNeil-PPC, Inc. Following the 2023 spin-off of Johnson & Johnson's consumer health business, many of McNeil's legacy brands are now managed by Kenvue, while its prescription products remain under the Janssen (J&J Innovative Medicine) umbrella. The entity played a crucial role in establishing J&J's dominance in the global analgesic and pediatric medicine markets.